[HTML][HTML] Integration and comparison of transcriptomic and proteomic data for meningioma
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - Cancers, 2020 - mdpi.com
Simple Summary Meningioma are the most common primary intracranial tumour, yet gaps in
their molecular characterisation persist and effective treatments for aggressive, recurring …
their molecular characterisation persist and effective treatments for aggressive, recurring …
[引用][C] Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta… - …, 2020 - research.birmingham.ac.uk
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma —
University of Birmingham Skip to main navigation Skip to search Skip to main content University …
University of Birmingham Skip to main navigation Skip to search Skip to main content University …
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma.
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - Cancers, 2020 - go.gale.com
Meningioma are the most common primary intracranial tumour, yet gaps in their molecular
characterisation persist and effective treatments for aggressive, recurring, high-grade (WHO …
characterisation persist and effective treatments for aggressive, recurring, high-grade (WHO …
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma.
J Dunn, VP Lenis, DA Hilton, R Warta… - …, 2020 - search.ebscohost.com
Abstract Simple Summary: Meningioma are the most common primary intracranial tumour,
yet gaps in their molecular characterisation persist and effective treatments for aggressive …
yet gaps in their molecular characterisation persist and effective treatments for aggressive …
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma.
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - Cancers, 2020 - europepmc.org
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta… - …, 2020 - research.tees.ac.uk
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …
[PDF][PDF] Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - core.ac.uk
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …
[HTML][HTML] Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - Cancers, 2020 - ncbi.nlm.nih.gov
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …
Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …
[PDF][PDF] Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma
J Dunn, VP Lenis, DA Hilton, R Warta, C Herold-Mende… - scholar.archive.org
Meningioma are the most frequent primary intracranial tumour. Management of aggressive
meningioma is complex, and development of effective biomarkers or pharmacological …
meningioma is complex, and development of effective biomarkers or pharmacological …